Where RNase L (37-kDa fragment) is reported
Also listed as: Antiviral pathway enzyme
| Condition | Direction | Compared against | Associated symptoms | Source |
|---|---|---|---|---|
| ME/CFS | ↑ elevated | healthy controls | Chronic immune activation | Maksoud et al. 2023 |
Frequently asked questions
In which conditions is RNase L (37-kDa fragment) altered?
In the OSMF atlas RNase L (37-kDa fragment) is reported in ME/CFS. It is elevated in 1 across 1 entries.
Is there a standard clinical test for RNase L (37-kDa fragment)?
The atlas entries for RNase L (37-kDa fragment) do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.
Is one abnormal RNase L (37-kDa fragment) result diagnostic?
No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.
Cite this page
Subscribe on Substack
Last reviewed: 2026-06-29 · Browse: Biomarker Index · All marker pages · Biomarker Atlas
Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.